J Mark Sloan, MD, is a hematologist at Boston Medical Center (BMC), specializing in benign and malignant blood disorders, including AL Amyloidosis, lymphoma, leukemia, multiple myeloma, and thrombosis. Dr. Sloan is also an associate professor of Medicine at Boston University Chobanian & Avedisian School of Medicine, a member of the Boston University-BMC Cancer Center, and a member of the Boston University Amyloidosis Center. Dr. Sloan received his medical degree and completed a fellowship at the Yale School of Medicine. He went on to complete a fellowship in hematology/oncology at Dana-Farber Cancer Institute and Massachusetts General Hospital. Dr. Sloan is a member of the Evans Center for Interdisciplinary Biomedical Research at Boston University, and his research interests focus on primary (AL) amyloidosis and HTLV-1 associated leukemia/lymphoma (ATLL).
  • Specialties

    AL Amyloidosis, lymphoma, leukemia, multiple myeloma, thrombosis, hemostasis, autologous stem cell transplantation.

  • Administrative Title

    Associate Professor of Medicine, Boston University Chobanian and Avedisian School of Medicine. Member, Boston University-BMC Cancer Center. Member, Boston University Amyloidosis Center.

  • Residency

    Internal Medicine, Yale-New Haven Medical Center, 2001-2004
  • Fellowship

    Hematology and Medical Oncology, Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute, 2005-2008
  • Education

    Yale University School of Medicine, 2001
  • Board Certifications

    Internal Medicine, Medical Oncology, and Hematology, American Board of Internal Medicine Certified in American Board of Internal Medicine